These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 21900582

  • 1. Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis.
    Wang J, Xu D, Wu X, Zhou C, Wang H, Guo Y, Cao K.
    Heart; 2011 Oct; 97(19):1542-6. PubMed ID: 21900582
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.
    Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J.
    Gene; 2013 Mar 15; 517(1):65-71. PubMed ID: 23313298
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P, Coto E, Reguero JR, Cannata-Andía JB, Lozano I, Avanzas P, Morís C, Rodríguez I.
    Coron Artery Dis; 2009 Sep 15; 20(6):383-6. PubMed ID: 19620856
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].
    Lu ZQ, Wang YM, Cao YY, Zhang QJ, Zhang XH, Li YH, Wang HS, Xie HL, Jiao BH, Zhang JH.
    Ai Zheng; 2007 May 15; 26(5):463-8. PubMed ID: 17672933
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B, Cao L, Ma X, Wang W, Wang D, Yu L.
    Mutagenesis; 2010 Jul 15; 25(4):371-9. PubMed ID: 20360147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.
    Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, Yuan S, Sun MH, Peng X, Wang BZ.
    Clin Appl Thromb Hemost; 2012 Jul 15; 18(1):72-8. PubMed ID: 21733941
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC, Lee HS, Chen WC, Shiu LJ, Yang SF, Wong RH.
    Ann Rheum Dis; 2009 Nov 15; 68(11):1781-6. PubMed ID: 19019896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study.
    Zhou X, Huang J, Chen J, Su S, Chen R, Gu D.
    Thromb Haemost; 2004 Oct 15; 92(4):867-73. PubMed ID: 15467919
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
    Liu PY, Chen JH, Li YH, Wu HL, Shi GY.
    Thromb Haemost; 2003 Jul 15; 90(1):132-9. PubMed ID: 12876636
    [Abstract] [Full Text] [Related]

  • 16. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer].
    Li Y, Wang Y, Kang S, Zhang JH, Guo W, Wang N, Jin X, Fang SM.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jul 15; 40(7):472-5. PubMed ID: 16080875
    [Abstract] [Full Text] [Related]

  • 17. Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and breast cancer risk: a meta-analysis.
    Zhou P, Du LF, Lv GQ, Yu XM, Gu YL, Li JP, Zhang C.
    Breast Cancer Res Treat; 2011 Jun 15; 127(3):813-8. PubMed ID: 21161369
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies.
    Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L.
    Mutagenesis; 2010 Jan 15; 25(1):41-8. PubMed ID: 19843588
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinase-1, -3, and -9 gene polymorphisms and the risk of idiopathic dilated cardiomyopathy in a Chinese Han population.
    Tang LJ, Chen XF, Zhu M, Jiang JJ, Lu XB, Du YX, Wang B, Fang CF, Xue YS, Shen WF.
    Clin Biochem; 2007 Dec 15; 40(18):1427-30. PubMed ID: 18028894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.